InvestRight Club Challenge Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : InvestRight Club Challenge

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bruce Cullen who wrote (1805)	5/4/1999 6:12:00 PM
From: Jeffrey L. Henken	Read Replies (1) of 2662

Skin is considered an organ. Here's another reason why ORG is up against it with short sellers: Wedbush Morgan Securities issued a Company Report on December 31, 1998 for Organogenesis Inc.. biz.yahoo.com On December 31, 1998 Wedbush Morgan Securities's Research Department issued a 1 page Company Report on Organogenesis Inc. Report highlights: 'The fiscal 1998 and 1999 EPS estimates were reduced to ($0.45) and ($0.41), from ($0.25) and ($0.34) per share, respectively. The downward earnings revisions reflect lower- than-expected top-line and bottom-line 3Q98 results. A SELL rating was maintained with a price target of $4 3/4 per share.' Believe me Bruce, I have absolutely no faith in analyst's reports. Everyone seems to be negative on ORG, but how did they get the stock so high in the first place? They will change their tunes. Unfortunately for now the stock may drift back to 52 week lows if they don't change their tune soon. On ATIS the situation is really quite a bit better. Technically Market Edge says buy. Me I'm not so sure. quote.yahoo.com Thanks, Jeff

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next